We have been producing clinical practice guidance on the management of patients with kidney disease since 1995.

The guidelines are not funded by any external organisation, commercial company or charity.

Our Clinical Practice Guideline (CPG) Committee have produced a Strategy Document to plan their work.

Dr Mark Devonald (consultant nephrologist, medical co-chair)

Andrea Devaney (consultant pharmacist, MPT co-chair)

Prof. James Burton (consultant nephrologist)

Katie Fielding (clinical doctoral research fellow)

Dr Katie Vinen (consultant nephrologist)

Dr Andrew Frankel (consultant nephrologist)

Wilfredo Manuel (nurse specialist)

Dr Evgenia Preka (paediatric nephrologist)

Kathrine Parker (renal pharmacist)

Dr Ellie Asgari (consultant nephrologist)

Dr Grace McCall (paediatric nephrologist)

Maha Mohamed (trainee)

Zoe Plummer (UKRR)

Dr James Fotheringham (consultant nephrologist)

Chris Herring (pharmacist)

Katie Durman (dietician)

Recent Guidelines

Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 Update - now available on the new interactive guidelines website